Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2904356201', 'doi': 'https://doi.org/10.1016/j.ymthe.2018.12.005', 'title': 'Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial', 'display_name': 'Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial', 'publication_year': 2018, 'publication_date': '2018-12-08', 'ids': {'openalex': 'https://openalex.org/W2904356201', 'doi': 'https://doi.org/10.1016/j.ymthe.2018.12.005', 'mag': '2904356201', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/30595526', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/6391590'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1016/j.ymthe.2018.12.005', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S51596929', 'display_name': 'Molecular Therapy', 'issn_l': '1525-0016', 'issn': ['1525-0016', '1525-0024'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'cc-by-nc-nd', 'license_id': 'https://openalex.org/licenses/cc-by-nc-nd', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'hybrid', 'oa_url': 'https://doi.org/10.1016/j.ymthe.2018.12.005', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5065382621', 'display_name': 'Torayuki Okuyama', 'orcid': 'https://orcid.org/0000-0003-3004-1412'}, 'institutions': [{'id': 'https://openalex.org/I4210132193', 'display_name': 'National Center For Child Health and Development', 'ror': 'https://ror.org/03fvwxc59', 'country_code': 'JP', 'type': 'government', 'lineage': ['https://openalex.org/I4210132193']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Torayuki Okuyama', 'raw_affiliation_strings': ['National Centre for Child Health and Development, Tokyo 157-8535, Japan'], 'affiliations': [{'raw_affiliation_string': 'National Centre for Child Health and Development, Tokyo 157-8535, Japan', 'institution_ids': ['https://openalex.org/I4210132193']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109869484', 'display_name': 'Yoshikatsu Eto', 'orcid': None}, 'institutions': [], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Yoshikatsu Eto', 'raw_affiliation_strings': ['Advanced Clinical Research Centre & Asian Lysosome Storage Disorder Centre, Institute of Neurological Disorders, Kawasaki 215-0026, Japan'], 'affiliations': [{'raw_affiliation_string': 'Advanced Clinical Research Centre & Asian Lysosome Storage Disorder Centre, Institute of Neurological Disorders, Kawasaki 215-0026, Japan', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101533762', 'display_name': 'Norio Sakai', 'orcid': 'https://orcid.org/0000-0003-3374-6709'}, 'institutions': [{'id': 'https://openalex.org/I4210111835', 'display_name': 'Osaka Health Science University', 'ror': 'https://ror.org/01tvqd679', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I4210111835']}, {'id': 'https://openalex.org/I98285908', 'display_name': 'Osaka University', 'ror': 'https://ror.org/035t8zc32', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I98285908']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Norio Sakai', 'raw_affiliation_strings': ['Osaka University, Course of Health Science, Osaka 565-0871, Japan'], 'affiliations': [{'raw_affiliation_string': 'Osaka University, Course of Health Science, Osaka 565-0871, Japan', 'institution_ids': ['https://openalex.org/I4210111835', 'https://openalex.org/I98285908']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102990852', 'display_name': 'Kohtaro Minami', 'orcid': 'https://orcid.org/0000-0003-4698-6250'}, 'institutions': [{'id': 'https://openalex.org/I4210095800', 'display_name': 'JCR Pharmaceuticals (Japan)', 'ror': 'https://ror.org/00vqs2b71', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210095800']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Kohtaro Minami', 'raw_affiliation_strings': ['JCR Pharmaceuticals, Ashiya 659-0021, Japan'], 'affiliations': [{'raw_affiliation_string': 'JCR Pharmaceuticals, Ashiya 659-0021, Japan', 'institution_ids': ['https://openalex.org/I4210095800']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109833896', 'display_name': 'Tatsuyoshi Yamamoto', 'orcid': 'https://orcid.org/0009-0007-7604-2011'}, 'institutions': [{'id': 'https://openalex.org/I4210095800', 'display_name': 'JCR Pharmaceuticals (Japan)', 'ror': 'https://ror.org/00vqs2b71', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210095800']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Tatsuyoshi Yamamoto', 'raw_affiliation_strings': ['JCR Pharmaceuticals, Ashiya 659-0021, Japan'], 'affiliations': [{'raw_affiliation_string': 'JCR Pharmaceuticals, Ashiya 659-0021, Japan', 'institution_ids': ['https://openalex.org/I4210095800']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102137370', 'display_name': 'Hiroyuki Sonoda', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210095800', 'display_name': 'JCR Pharmaceuticals (Japan)', 'ror': 'https://ror.org/00vqs2b71', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210095800']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Hiroyuki Sonoda', 'raw_affiliation_strings': ['JCR Pharmaceuticals, Ashiya 659-0021, Japan'], 'affiliations': [{'raw_affiliation_string': 'JCR Pharmaceuticals, Ashiya 659-0021, Japan', 'institution_ids': ['https://openalex.org/I4210095800']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023508083', 'display_name': 'Mariko Yamaoka', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210095800', 'display_name': 'JCR Pharmaceuticals (Japan)', 'ror': 'https://ror.org/00vqs2b71', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210095800']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Mariko Yamaoka', 'raw_affiliation_strings': ['JCR Pharmaceuticals, Ashiya 659-0021, Japan'], 'affiliations': [{'raw_affiliation_string': 'JCR Pharmaceuticals, Ashiya 659-0021, Japan', 'institution_ids': ['https://openalex.org/I4210095800']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101135801', 'display_name': 'Katsuhiko Tachibana', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210095800', 'display_name': 'JCR Pharmaceuticals (Japan)', 'ror': 'https://ror.org/00vqs2b71', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210095800']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Katsuhiko Tachibana', 'raw_affiliation_strings': ['JCR Pharmaceuticals, Ashiya 659-0021, Japan'], 'affiliations': [{'raw_affiliation_string': 'JCR Pharmaceuticals, Ashiya 659-0021, Japan', 'institution_ids': ['https://openalex.org/I4210095800']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043488602', 'display_name': 'Tohru Hirato', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210095800', 'display_name': 'JCR Pharmaceuticals (Japan)', 'ror': 'https://ror.org/00vqs2b71', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210095800']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Tohru Hirato', 'raw_affiliation_strings': ['JCR Pharmaceuticals, Ashiya 659-0021, Japan'], 'affiliations': [{'raw_affiliation_string': 'JCR Pharmaceuticals, Ashiya 659-0021, Japan', 'institution_ids': ['https://openalex.org/I4210095800']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5040926154', 'display_name': 'Yuji Sato', 'orcid': 'https://orcid.org/0000-0002-5185-8643'}, 'institutions': [{'id': 'https://openalex.org/I4210095800', 'display_name': 'JCR Pharmaceuticals (Japan)', 'ror': 'https://ror.org/00vqs2b71', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210095800']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Yuji Sato', 'raw_affiliation_strings': ['JCR Pharmaceuticals, Ashiya 659-0021, Japan'], 'affiliations': [{'raw_affiliation_string': 'JCR Pharmaceuticals, Ashiya 659-0021, Japan', 'institution_ids': ['https://openalex.org/I4210095800']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 4, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3900, 'currency': 'USD', 'value_usd': 3900, 'provenance': 'doaj'}, 'apc_paid': {'value': 3900, 'currency': 'USD', 'value_usd': 3900, 'provenance': 'doaj'}, 'fwci': 8.287, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 120, 'citation_normalized_percentile': {'value': 0.844039, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 98, 'max': 99}, 'biblio': {'volume': '27', 'issue': '2', 'first_page': '456', 'last_page': '464'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10945', 'display_name': 'Lysosomal Storage Disorders Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10945', 'display_name': 'Lysosomal Storage Disorders Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12604', 'display_name': 'Glycogen Storage Diseases and Myoclonus', 'score': 0.9914, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10890', 'display_name': 'Trypanosoma species research and implications', 'score': 0.9879, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/hunter-syndrome', 'display_name': 'Hunter syndrome', 'score': 0.9672748}, {'id': 'https://openalex.org/keywords/mucopolysaccharidosis-type-ii', 'display_name': 'Mucopolysaccharidosis type II', 'score': 0.8392166}, {'id': 'https://openalex.org/keywords/transferrin-receptor', 'display_name': 'Transferrin receptor', 'score': 0.6438893}, {'id': 'https://openalex.org/keywords/mucopolysaccharidosis', 'display_name': 'Mucopolysaccharidosis', 'score': 0.5371789}, {'id': 'https://openalex.org/keywords/hurler-syndrome', 'display_name': 'Hurler syndrome', 'score': 0.50046754}, {'id': 'https://openalex.org/keywords/dermatan-sulfate', 'display_name': 'Dermatan sulfate', 'score': 0.4172265}], 'concepts': [{'id': 'https://openalex.org/C2776225084', 'wikidata': 'https://www.wikidata.org/wiki/Q1529983', 'display_name': 'Hunter syndrome', 'level': 2, 'score': 0.9672748}, {'id': 'https://openalex.org/C2910638406', 'wikidata': 'https://www.wikidata.org/wiki/Q1529983', 'display_name': 'Mucopolysaccharidosis type II', 'level': 4, 'score': 0.8392166}, {'id': 'https://openalex.org/C32264632', 'wikidata': 'https://www.wikidata.org/wiki/Q1134983', 'display_name': 'Transferrin receptor', 'level': 3, 'score': 0.6438893}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.63757306}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.5381791}, {'id': 'https://openalex.org/C2779416428', 'wikidata': 'https://www.wikidata.org/wiki/Q1479681', 'display_name': 'Mucopolysaccharidosis', 'level': 2, 'score': 0.5371789}, {'id': 'https://openalex.org/C2777636572', 'wikidata': 'https://www.wikidata.org/wiki/Q25379699', 'display_name': 'Hurler syndrome', 'level': 3, 'score': 0.50046754}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.47226965}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.4458019}, {'id': 'https://openalex.org/C22814914', 'wikidata': 'https://www.wikidata.org/wiki/Q410473', 'display_name': 'Transferrin', 'level': 2, 'score': 0.44088203}, {'id': 'https://openalex.org/C2779651940', 'wikidata': 'https://www.wikidata.org/wiki/Q54196', 'display_name': 'Cerebrospinal fluid', 'level': 2, 'score': 0.4320482}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.4193096}, {'id': 'https://openalex.org/C2778066728', 'wikidata': 'https://www.wikidata.org/wiki/Q2335618', 'display_name': 'Dermatan sulfate', 'level': 4, 'score': 0.4172265}, {'id': 'https://openalex.org/C2779969927', 'wikidata': 'https://www.wikidata.org/wiki/Q916766', 'display_name': 'Enzyme replacement therapy', 'level': 3, 'score': 0.38501263}, {'id': 'https://openalex.org/C2778041096', 'wikidata': 'https://www.wikidata.org/wiki/Q424668', 'display_name': 'Heparan sulfate', 'level': 3, 'score': 0.36828655}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.14573082}, {'id': 'https://openalex.org/C2777557582', 'wikidata': 'https://www.wikidata.org/wiki/Q190016', 'display_name': 'Heparin', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000906', 'descriptor_name': 'Antibodies', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D007066', 'descriptor_name': 'Iduronate Sulfatase', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D016532', 'descriptor_name': 'Mucopolysaccharidosis II', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D011990', 'descriptor_name': 'Receptors, Transferrin', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D000293', 'descriptor_name': 'Adolescent', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000906', 'descriptor_name': 'Antibodies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001812', 'descriptor_name': 'Blood-Brain Barrier', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002648', 'descriptor_name': 'Child', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003071', 'descriptor_name': 'Cognition', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003071', 'descriptor_name': 'Cognition', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D004195', 'descriptor_name': 'Disease Models, Animal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D056947', 'descriptor_name': 'Enzyme Replacement Therapy', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007066', 'descriptor_name': 'Iduronate Sulfatase', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007066', 'descriptor_name': 'Iduronate Sulfatase', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016532', 'descriptor_name': 'Mucopolysaccharidosis II', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011990', 'descriptor_name': 'Receptors, Transferrin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D055815', 'descriptor_name': 'Young Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1016/j.ymthe.2018.12.005', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S51596929', 'display_name': 'Molecular Therapy', 'issn_l': '1525-0016', 'issn': ['1525-0016', '1525-0024'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'cc-by-nc-nd', 'license_id': 'https://openalex.org/licenses/cc-by-nc-nd', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc6391590', 'pdf_url': 'https://europepmc.org/articles/pmc6391590?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': 'cc-by-nc-nd', 'license_id': 'https://openalex.org/licenses/cc-by-nc-nd', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391590', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/30595526', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1016/j.ymthe.2018.12.005', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S51596929', 'display_name': 'Molecular Therapy', 'issn_l': '1525-0016', 'issn': ['1525-0016', '1525-0024'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'cc-by-nc-nd', 'license_id': 'https://openalex.org/licenses/cc-by-nc-nd', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.8, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [{'funder': 'https://openalex.org/F4320307781', 'funder_display_name': 'Sanofi', 'award_id': None}, {'funder': 'https://openalex.org/F4320309052', 'funder_display_name': 'Alexion Pharmaceuticals', 'award_id': None}, {'funder': 'https://openalex.org/F4320309705', 'funder_display_name': 'Shire', 'award_id': None}, {'funder': 'https://openalex.org/F4320310557', 'funder_display_name': 'BioMarin Pharmaceutical', 'award_id': None}, {'funder': 'https://openalex.org/F4320321627', 'funder_display_name': 'Dainippon Sumitomo Pharma', 'award_id': None}], 'datasets': [], 'versions': [], 'referenced_works_count': 31, 'referenced_works': ['https://openalex.org/W1498673086', 'https://openalex.org/W1964975620', 'https://openalex.org/W1967386288', 'https://openalex.org/W1968265417', 'https://openalex.org/W1993027304', 'https://openalex.org/W1993518098', 'https://openalex.org/W1996799982', 'https://openalex.org/W1997831257', 'https://openalex.org/W2012973972', 'https://openalex.org/W2020409398', 'https://openalex.org/W2025061302', 'https://openalex.org/W2027190940', 'https://openalex.org/W2033935474', 'https://openalex.org/W2102067858', 'https://openalex.org/W2106493886', 'https://openalex.org/W2109699895', 'https://openalex.org/W2110569992', 'https://openalex.org/W2112373900', 'https://openalex.org/W2133765656', 'https://openalex.org/W2137541358', 'https://openalex.org/W2138037217', 'https://openalex.org/W2148045371', 'https://openalex.org/W2162676548', 'https://openalex.org/W2584577473', 'https://openalex.org/W2617895008', 'https://openalex.org/W2737246508', 'https://openalex.org/W2754733929', 'https://openalex.org/W2765910122', 'https://openalex.org/W2793073482', 'https://openalex.org/W2830135676', 'https://openalex.org/W2884044665'], 'related_works': ['https://openalex.org/W820401292', 'https://openalex.org/W2755436125', 'https://openalex.org/W2342506134', 'https://openalex.org/W2276056773', 'https://openalex.org/W2159157292', 'https://openalex.org/W2145402228', 'https://openalex.org/W2105890212', 'https://openalex.org/W2078756780', 'https://openalex.org/W2066349623', 'https://openalex.org/W2015597043'], 'abstract_inverted_index': {'Hunter': [0], 'syndrome': [1], '(mucopolysaccharidosis': [2], 'II': [3], '[MPS': [4], 'II]),': [5], 'a': [6, 89, 122], 'deficiency': [7], 'of': [8, 14, 80, 109, 147, 176], 'iduronate-2-sulfatase': [9], '(IDS),': [10], 'causes': [11], 'an': [12], 'accumulation': [13], 'glycosaminoglycans,': [15], 'giving': [16], 'rise': [17], 'to': [18, 59], 'multiple': [19], 'systemic': [20], 'and': [21, 29, 63, 77, 102, 112, 139, 151, 160, 162, 178, 191], 'CNS': [22, 36, 194], 'symptoms.': [23, 180], 'The': [24], 'currently': [25], 'available': [26], 'therapies,': [27], 'idursulfase': [28, 30], 'beta,': [31], 'are': [32], 'ineffective': [33], 'against': [34], 'the': [35, 42, 61, 74, 130, 137, 185, 189], 'symptoms': [37], 'because': [38], 'they': [39], 'cannot': [40], 'pass': [41], 'blood-brain': [43], 'barrier': [44], '(BBB).': [45], 'A': [46], 'novel': [47], 'IDS': [48], 'fused': [49], 'with': [50, 85], 'anti-human': [51], 'transferrin': [52], 'receptor': [53], 'antibody': [54], '(JR-141)': [55], 'has': [56], 'been': [57], 'shown': [58], 'penetrate': [60], 'BBB': [62, 190], 'ameliorate': [64], 'learning': [65], 'deficits': [66], 'in': [67, 82, 93, 157, 168], 'model': [68], 'mice.': [69], 'This': [70], 'first-in-human': [71], 'study': [72, 91], 'evaluated': [73], 'pharmacokinetics,': [75], 'safety,': [76], 'potential': [78], 'efficacy': [79], 'JR-141': [81, 96], '14': [83], 'patients': [84, 172], 'MPS': [86], 'II.': [87], 'In': [88, 121], 'dose-escalation': [90], 'performed': [92], 'two': [94, 127], 'patients,': [95], 'plasma': [97, 131, 159], 'concentrations': [98], 'were': [99, 119, 134, 155, 165], 'dose': [100, 128], 'dependent': [101], 'peaked': [103], 'at': [104, 126], '3': [105], 'hr': [106], 'after': [107], 'initiation': [108], 'each': [110], 'infusion,': [111], 'no': [113, 143], 'or': [114], 'only': [115], 'mild': [116], 'adverse': [117], 'reactions': [118], 'exhibited.': [120], 'subsequent': [123], '4-week': [124], 'evaluation': [125], 'levels,': [129], 'concentration': [132], 'profiles': [133], 'similar': [135], 'between': [136], 'first': [138], 'final': [140], 'administration,': [141], 'indicating': [142], 'drug': [144, 186], 'accumulation.': [145], 'Levels': [146], 'heparan': [148], 'sulfate': [149, 153], '(HS)': [150], 'dermatan': [152], '(DS)': [154], 'suppressed': [156], 'both': [158], 'urine': [161], 'HS': [163], 'levels': [164], 'significantly': [166], 'decreased': [167], 'cerebrospinal': [169], 'fluid.': [170], 'Two': [171], 'experienced': [173], 'some': [174], 'amelioration': [175], 'neurocognitive': [177], 'motor': [179], 'These': [181], 'results': [182], 'suggest': [183], 'that': [184], 'successfully': [187], 'penetrates': [188], 'could': [192], 'have': [193], 'efficacy.': [195]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2904356201', 'counts_by_year': [{'year': 2024, 'cited_by_count': 20}, {'year': 2023, 'cited_by_count': 29}, {'year': 2022, 'cited_by_count': 17}, {'year': 2021, 'cited_by_count': 23}, {'year': 2020, 'cited_by_count': 23}, {'year': 2019, 'cited_by_count': 8}], 'updated_date': '2024-12-08T21:10:46.199866', 'created_date': '2018-12-22'}